165 related articles for article (PubMed ID: 28122920)
1. Combined TRAF6 Targeting and Proteasome Blockade Has Anti-myeloma and Anti-Bone Resorptive Effects.
Chen H; Li M; Sanchez E; Wang CS; Lee T; Soof CM; Casas CE; Cao J; Xie C; Udd KA; DeCorso K; Tang GY; Spektor TM; Berenson JR
Mol Cancer Res; 2017 May; 15(5):598-609. PubMed ID: 28122920
[TBL] [Abstract][Full Text] [Related]
2. Interference with nuclear factor kappa B and c-Jun NH2-terminal kinase signaling by TRAF6C small interfering RNA inhibits myeloma cell proliferation and enhances apoptosis.
Chen H; Li M; Campbell RA; Burkhardt K; Zhu D; Li SG; Lee HJ; Wang C; Zeng Z; Gordon MS; Bonavida B; Berenson JR
Oncogene; 2006 Oct; 25(49):6520-7. PubMed ID: 16702955
[TBL] [Abstract][Full Text] [Related]
3. TRAF6 Silencing Attenuates Multiple Myeloma Cell Adhesion to Bone Marrow Stromal Cells.
Morgan JJ; McAvera RM; Crawford LJ
Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30736330
[TBL] [Abstract][Full Text] [Related]
4. Proteasome inhibitors impair RANKL-induced NF-kappaB activity in osteoclast-like cells via disruption of p62, TRAF6, CYLD, and IkappaBalpha signaling cascades.
Ang E; Pavlos NJ; Rea SL; Qi M; Chai T; Walsh JP; Ratajczak T; Zheng MH; Xu J
J Cell Physiol; 2009 Aug; 220(2):450-9. PubMed ID: 19365810
[TBL] [Abstract][Full Text] [Related]
5. TRAF6 activation in multiple myeloma: a potential therapeutic target.
Liu H; Tamashiro S; Baritaki S; Penichet M; Yu Y; Chen H; Berenson J; Bonavida B
Clin Lymphoma Myeloma Leuk; 2012 Jun; 12(3):155-63. PubMed ID: 22440007
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of parthenolide on the activity of NF-κB in multiple myeloma via targeting TRAF6.
Kong FC; Zhang JQ; Zeng C; Chen WL; Ren WX; Yan GX; Wang HX; Li QB; Chen ZC
J Huazhong Univ Sci Technolog Med Sci; 2015 Jun; 35(3):343-349. PubMed ID: 26072071
[TBL] [Abstract][Full Text] [Related]
7. TRAF6 is required for BLyS-mediated NF-κB signaling in multiple myeloma cells.
Wang X; Wang J; Liu H; Xu R; Ding R; Jiang S; Wang X; Huang H
Med Oncol; 2015 Oct; 32(10):239. PubMed ID: 26334396
[TBL] [Abstract][Full Text] [Related]
8. NEDD8 Inhibition Overcomes CKS1B-Induced Drug Resistance by Upregulation of p21 in Multiple Myeloma.
Huang J; Zhou Y; Thomas GS; Gu Z; Yang Y; Xu H; Tricot G; Zhan F
Clin Cancer Res; 2015 Dec; 21(24):5532-42. PubMed ID: 26156395
[TBL] [Abstract][Full Text] [Related]
9. Synergistic targeting of Sp1, a critical transcription factor for myeloma cell growth and survival, by panobinostat and proteasome inhibitors.
Bat-Erdene A; Miki H; Oda A; Nakamura S; Teramachi J; Amachi R; Tenshin H; Hiasa M; Iwasa M; Harada T; Fujii S; Sogabe K; Kagawa K; Yoshida S; Endo I; Aihara K; Abe M
Oncotarget; 2016 Nov; 7(48):79064-79075. PubMed ID: 27738323
[TBL] [Abstract][Full Text] [Related]
10. Sensitivity of TLR4- and -7-induced NF kappa B1 p105-TPL2-ERK pathway to TNF-receptor-associated-factor-6 revealed by RNAi in mouse macrophages.
Loniewski KJ; Patial S; Parameswaran N
Mol Immunol; 2007 Jul; 44(15):3715-23. PubMed ID: 17507094
[TBL] [Abstract][Full Text] [Related]
11. TRAF6 is functional in inhibition of TLR4-mediated NF-κB activation by resveratrol.
Jakus PB; Kalman N; Antus C; Radnai B; Tucsek Z; Gallyas F; Sumegi B; Veres B
J Nutr Biochem; 2013 May; 24(5):819-23. PubMed ID: 22925919
[TBL] [Abstract][Full Text] [Related]
12. Bortezomib could down-regulate the expression of RANKL, inhibit cell proliferation and induce cell apoptosis in the human myeloma cell line RPMI 8226 by activating casepase-3.
Lin L; Chen D; Xiang ZF; Pei RZ; Zhang PS; Liu XH; Du XH; Lu Y
Cancer Biomark; 2017 Aug; 20(2):217-224. PubMed ID: 28869453
[TBL] [Abstract][Full Text] [Related]
13.
Bolzoni M; Ronchetti D; Storti P; Donofrio G; Marchica V; Costa F; Agnelli L; Toscani D; Vescovini R; Todoerti K; Bonomini S; Sammarelli G; Vecchi A; Guasco D; Accardi F; Palma BD; Gamberi B; Ferrari C; Neri A; Aversa F; Giuliani N
Haematologica; 2017 Apr; 102(4):773-784. PubMed ID: 28057743
[TBL] [Abstract][Full Text] [Related]
14. Bid Promotes K63-Linked Polyubiquitination of Tumor Necrosis Factor Receptor Associated Factor 6 (TRAF6) and Sensitizes to Mutant SOD1-Induced Proinflammatory Signaling in Microglia.
Kinsella S; König HG; Prehn JH
eNeuro; 2016; 3(2):. PubMed ID: 27257617
[TBL] [Abstract][Full Text] [Related]
15. Epigallocatechin-3-gallate(EGCG) suppresses melanoma cell growth and metastasis by targeting TRAF6 activity.
Zhang J; Lei Z; Huang Z; Zhang X; Zhou Y; Luo Z; Zeng W; Su J; Peng C; Chen X
Oncotarget; 2016 Nov; 7(48):79557-79571. PubMed ID: 27791197
[TBL] [Abstract][Full Text] [Related]
16. [Effects of down-regulated TRAF6 gene expression on the proliferation and apoptosis in multiple myeloma cells].
Huang HM; Wang XF; Liu XX; Xu RR; Shi W; Ding RS; Jiang SH
Zhonghua Xue Ye Xue Za Zhi; 2013 Nov; 34(11):941-5. PubMed ID: 24294849
[TBL] [Abstract][Full Text] [Related]
17. IRAK-1-mediated negative regulation of Toll-like receptor signaling through proteasome-dependent downregulation of TRAF6.
Muroi M; Tanamoto K
Biochim Biophys Acta; 2012 Feb; 1823(2):255-63. PubMed ID: 22033459
[TBL] [Abstract][Full Text] [Related]
18. Targeting the cross-talk between the hedgehog and NF-κB signaling pathways in multiple myeloma.
Cai K; Na W; Guo M; Xu R; Wang X; Qin Y; Wu Y; Jiang J; Huang H
Leuk Lymphoma; 2019 Mar; 60(3):772-781. PubMed ID: 30644322
[TBL] [Abstract][Full Text] [Related]
19. JNK/c-Jun signaling mediates an anti-apoptotic effect of RANKL in osteoclasts.
Ikeda F; Matsubara T; Tsurukai T; Hata K; Nishimura R; Yoneda T
J Bone Miner Res; 2008 Jun; 23(6):907-14. PubMed ID: 18251700
[TBL] [Abstract][Full Text] [Related]
20. SMN1 functions as a novel inhibitor for TRAF6-mediated NF-κB signaling.
Kim EK; Choi EJ
Biochim Biophys Acta Mol Cell Res; 2017 May; 1864(5):760-770. PubMed ID: 28214532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
